Beijing Tiantan Biological Products Corp. Ltd. (600161.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 12.15

From 52W high−40.71%

Volume7.37M

Market capCNY 23.61B

P/E (TTM)21.6x

P/S (TTM)4.0x

Div yield1.64%

Key dataSep 18, 2026

Open

CNY 12.15

From 52W high

−40.71%

Volume

7.37M

Market cap

CNY 23.61B

ValuationView details →

P/E (Fwd)

21.2x

EV/EBITDA

11.3x

P/E (TTM)

21.6x

RSI (14)

46.7

MomentumView details →

1D Return

−1.73%

YTD Return

−25.52%

ValuationView details →

P/E (Fwd)

21.2x

P/E (TTM)

21.6x

EV/EBITDA

11.3x

EV/Sales

4.3x

P/S (TTM)

4.0x

P/B (TTM)

2.0x

ProfitabilityView details →

Gross Margin

41.64%

Net Margin

16.23%

EBITDA Margin

38.30%

ROE (TTM)

8.20%

ROA (TTM)

5.83%

Asset Turnover

0.36x

GrowthView details →

Revenue YoY

−2.21%

EPS YoY

−34.48%

FCF YoY

+97.35%

Revenue CAGR 3Y

+13.12%

EPS CAGR 3Y

+1.24%

EBITDA YoY

—

MomentumView details →

1D Return

−1.73%

YTD Return

−25.52%

1Y Return

−37.17%

RSI (14)

46.7

vs 50D SMA

−2.11%

vs 200D SMA

−15.72%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

8.82x

Quick Ratio

4.44x

Div Yield

1.64%

Div Rate

CNY 0.20

Div Growth 1Y

+66.67%

EarningsView details →

EPS (Actual)

CNY 0.14

EPS Surprise

52.20%

Beats (12Q)

1/12

Next Q EPS Est

CNY 0.11

Avg Surprise (4Q)

52.20%

Rev Surprise

16.18%

Financials snapshotView financials →

Revenue (TTM)

5.99B

Net Income (TTM)

972.56M

Op. CF (TTM)

624.88M

Next earningsOct 22, 2026 →

Latest newsMore news →

Tiantan Biological's four subsidiaries received single plasma collection licenses from the Gansu Provincial Health Commission, allowing them to operate.13d ago

Tiantan Biological announced a cash dividend of 1 yuan per 10 shares (tax included) based on the total share capital of 1.977 billion shares as of the end of June 2026, with a total dividend amount of 198 million yuan (tax included).23d ago

Similar companies

BioNTech SEBNTX 特宝生物688278.SH Zai Lab Limited09688.HK Biocytogen Pharmaceuticals (Beijing) Co., Ltd.02315.HK Incyte CorporationINCY Keymed Biosciences Inc.02162.HK Find similar companies →

Latest newsMore news →

Tiantan Biological's four subsidiaries received single plasma collection licenses from the Gansu Provincial Health Commission, allowing them to operate.13d ago Tiantan Biological announced a cash dividend of 1 yuan per 10 shares (tax included) based on the total share capital of 1.977 billion shares as of the end of June 2026, with a total dividend amount of 198 million yuan (tax included).23d ago